Growth Metrics

Sonoma Pharmaceuticals (SNOA) Long-Term Debt Issuances (2017 - 2020)

Sonoma Pharmaceuticals has reported Long-Term Debt Issuances over the past 6 years, most recently at $1.3 million for Q2 2020.

  • For Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to $1.3 million; the TTM value through Dec 2021 reached $1.3 million, changed 0.0%, while the annual FY2019 figure was -$324000.0, 145.45% down from the prior year.
  • Long-Term Debt Issuances for Q2 2020 was $1.3 million at Sonoma Pharmaceuticals, up from -$215000.0 in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $1.3 million in Q2 2020 and troughed at -$215000.0 in Q1 2019.
  • A 4-year average of $94888.9 and a median of -$35000.0 in 2018 define the central range for Long-Term Debt Issuances.
  • Biggest five-year swings in Long-Term Debt Issuances: dropped 12.12% in 2018 and later plummeted 514.29% in 2019.
  • Year by year, Long-Term Debt Issuances stood at -$33000.0 in 2017, then dropped by 12.12% to -$37000.0 in 2018, then crashed by 481.08% to -$215000.0 in 2019, then surged by 709.3% to $1.3 million in 2020.
  • Business Quant data shows Long-Term Debt Issuances for SNOA at $1.3 million in Q2 2020, -$215000.0 in Q1 2019, and -$37000.0 in Q4 2018.